Other Income & Expense
Other Non-Cash Items
Vertex Pharmaceuticals Other Non-Cash Items increased by 121.6% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 112.8%, from -$39.20M to $5.00M. Over 3 years (FY 2022 to FY 2025), Other Non-Cash Items shows a downward trend with a 116.7% CAGR.
Analysis
StatementIncome Statement
SectionOther Income & Expense
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
Metric ID:
amgn_other_noncash_income_expenseHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.90M | -$9.30M | -$4.90M | $11.20M | $26.50M | -$44.60M | $10.65M | $10.65M | $10.65M | $10.65M | $36.40M | $20.70M | -$41.60M | -$16.40M | -$39.20M | -$57.80M | $0.00 | -$23.10M | $5.00M |
| QoQ Change | — | -4.5% | +47.3% | +328.6% | +136.6% | -268.3% | +123.9% | +0.0% | +0.0% | +0.0% | +241.8% | -43.1% | -301.0% | +60.6% | -139.0% | -47.4% | +100.0% | — | +121.6% |
| YoY Change | — | — | — | +225.8% | +384.9% | — | +317.3% | -4.9% | -59.8% | +123.9% | +241.8% | +94.4% | -490.6% | -254.0% | -207.7% | -379.2% | +100.0% | -40.9% | +112.8% |
Range-$57.80M – $36.40M
CAGR-12.0%
Avg YoY Growth+10.9%
Median YoY Growth+94.4%
Other Non-Cash Items at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other non-cash items?
- Vertex Pharmaceuticals (VRTX) reported other non-cash items of $5.00M in Q1 2026.
- How has Vertex Pharmaceuticals's other non-cash items changed year-over-year?
- Vertex Pharmaceuticals's other non-cash items increased by 112.8% year-over-year, from -$39.20M to $5.00M.
- What is the long-term trend for Vertex Pharmaceuticals's other non-cash items?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's other non-cash items has grown at a 116.7% compound annual growth rate (CAGR), from -$11.80M to -$120.10M.